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While most transcription factors exit the chromatin during
mitosis and the genome becomes silent, a subset of factors
remains and “bookmark” genes for rapid re-activation as
cells progress through the cell cycle. Yet it is unknown
whether such “bookmarking” factors bind to chromatin
similarly in mitosis and how different binding capacities
among them relate to function. We compared a diverse set
of transcription factors involved in liver differentiation and
found markedly different extents of mitotic chromosome
binding. Among them, only the pioneer factor FoxA1 exhi-
bits virtually complete mitotic chromosome binding. Geno-
mically, about 15% of the FoxA1 interphase target sites are
bound in mitosis, including at genes for liver differentia-
tion. Biophysical, genome mapping, and mutagenesis stu-
dies of FoxA1 reveals two different modes of binding to
mitotic chromatin: Specific binding, at sites that continue
to be bound from interphase, and nonspecific binding,
whereby due to intrinsic chromatin affinity, FoxA1 remains
in the genomic vicinity of its interphase target genes. Both
specific and nonspecific binding contribute to timely reacti-
vation of target genes, post mitosis. These studies reveal an
unexpected diversity in the mechanisms by which tran-
scription factors help retain cell identity during mitosis.
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